Latest Conference Articles

With more than 60 presentations at the American Diabetes Association's meeting AstraZeneca showed a wide range of studies all geared towards helping patients with this condition.

Adding liraglutide to insulin treatment for type 1 diabetes has proven to lower body weight and reduce the frequency of hypoglycemia. Potential heart risks, however, have yet to be established.

When patients enter the hospital monitoring their blood glucose can be even more important to limit the effects of hypoglycemia. If the condition does develop it can make the stays longer and more expensive for everyone involved.

Blood glucose monitoring is an important part of patient care no matter where it is done, but it can be particularly important in hospital settings.

The field of diabetes care is continually moving forward. Even as data was being presented at this year's meeting of the American Diabetes Association the future was at the forefront of many people's minds in an effort to help these patients even more.

Even as gastric bypass continues to be a proven surgical option in the fight against the obesity epidemic work still remains to find a therapeutic option for this patient population as well.

There is no question that hunger can affect a person's life, a recent study looked at the scientific aspect of this discussion and what doctors can do to help patients with this challenge.

Especially for children with diagnosed with type 1 diabetes their journey with the condition will last decades affecting not only themselves but those around them. This is also true for patients with type 2 diabetes and how they confront these challenges can affect their life outside of diabetes as well.

Patients with type 2 diabetes are especially at risk for getting the hepatitis B infection, and a new vaccine proved to work better than the current one during a phase III trial.

“Early diabetic kidney disease (DKD), including increased albumin excretion and renal hyperfiltration (HF), is common in youth with type 2 diabetes,†a collaborative team of researchers began in a poster session at the American Diabetes Association (ADA 2016) 76th Scientific Sessions in New Orleans, Louisiana.

IBM Watson Health is working on several projects of their own as well as with partners in the field to move the treatment of diabetes forward in an effort to hep as many patients as possible.

At the recent ASCO conference in Chicago it was announced that Watson Health would be used to help with cancer treatment. A similar announcement was made at the American Diabetes Association's annual meeting in New Orleans.

As the treatment of diabetes becomes more complicated with a multitude of options on the market a long time member of the medical technology community is taking a big step to help fight this epidemic.

Everyone needs an adequate amount of sleep every night, but it should especially be a priority in pregnant women. However, there is a fine line between too much and too little sleep, but either way, both sides of the spectrum have an increase risk in gestational diabetes.

The obesity epidemic continues to grow in this country leaving the medical community to find new ways to help this patient population.

Maternal health just got that much more important as new research finds obesity contributes to chronic kidney disease risk in children.

Many healthcare providers have been pushing for the approval of insulin degludec/liraglutide (IDegLira) and the latest safety and efficacy results could help finally do that.

Not much is known about the relationship between oral contraceptives use and diabetes, but this untapped area got the spotlight during a session at the American Diabetes Association (ADA 2016) 76th Scientific Sessions in New Orleans, Louisiana.

Patients with type 1 diabetes can safely lower their blood glucose levels and hypoglycemia in a home setting with the dual hormone (glucagon and insulin) bionic pancreas, a new study revealed at the American Diabetes Association (ADA 2016) 76th Scientific Sessions in New Orleans, Louisiana.

A fair amount of women who are diagnosed with gestational diabetes take active measures to lose weight – but what clinical outcomes does that have?

Vitamin D and diabetes have a rocky relationship, but new insight was revealed at the American Diabetes Association (ADA 2016) 76th Scientific Sessions in New Orleans, Louisiana.

What happens when a patient with type 2 diabetes uses both a potassium (K)-sparing agent and sodium-glucose co-transporter 2 (SGLT2) inhibitor at the same time?

Statistics coming from controlled trials can be challenging to apply to the real-world. But a new study assessing the use of dapagliflozin for type 2 diabetes in real clinical use yielded important insight.

New research presented at the American Diabetes Association (ADA 2016) 76th Scientific Sessions in New Orleans, Louisiana makes a case for autologous transplantation.

Pig cell transplantation could take the place of a blood glucose level-improving surgery for patients with type 1 diabetes.

It was not that long ago when doctors would sometimes not discuss the diagnosis of multiple sclerosis with their patients. Now not only is it a condition they can diagnose but treatment is also progressing by leaps and bounds.

Newly approved and longstanding treatment options are definitely an important part of the overall care picture but there is more work for a doctor to do beyond filling out a prescription pad.

As the treatment of relapsing remitting multiple sclerosis continues to add new treatment methods patients with progressive forms of the condition are still waiting for their first approved medication to manage their symptoms.

Acknowledging that uncertainty is a key factor in the care and treatment of multiple sclerosis is part of a solution to a problem, finding the best way to deal with that uncertainty is another issue that must be confronted by patients and doctors alike.

From the time a patient is diagnosed with multiple sclerosis there are often more questions than answers for extended periods of time. What that means for their care and management of symptoms is the subject of a recent study.